A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Gary Gordon, MD
AbbVie
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
48 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Site Reference Id/investigator# 3337
Brno, Czechia
- Site Reference Id/investigator# 4687
Brno, Czechia
- Site Reference Id/investigator# 4278
Kyjov, Czechia
- Site Reference Id/investigator# 3328
Nový Jičín, Czechia
- Site Reference Id/investigator# 3327
Olomouc, Czechia
- Site Reference Id/investigator# 3343
Ostrava-Poruba, Czechia
- Site Reference Id/investigator# 3342
Prague, Czechia
- Site Reference Id/investigator# 3344
Prague, Czechia
- Site Reference Id/investigator# 3411
Příbram, Czechia
- Site Reference Id/investigator# 3405
Heraklion, Greece
- Site Reference Id/investigator# 3403
Thessaloniki, Greece
- Site Reference Id/investigator# 3406
Thessaloniki, Greece
- Site Reference Id/investigator# 3331
Budapest, Hungary
- Site Reference Id/investigator# 3333
Miskolc, Hungary
- Site Reference Id/investigator# 3332
Székesfehérvár, Hungary
- Site Reference Id/investigator# 3409
Amsterdam, Netherlands
- Site Reference Id/investigator# 3319
Eindhoven, Netherlands
- Site Reference Id/investigator# 3341
Haraderwijk, Netherlands
- Site Reference Id/investigator# 3528
Hoorn, Netherlands
- Site Reference Id/investigator# 3400
Bratislava, Slovakia
- Site Reference Id/investigator# 3410
Martin, Slovakia
- Site Reference Id/investigator# 3358
Fayetteville, Arkansas, United States
- Site Reference Id/investigator# 4102
Hot Springs, Arkansas, United States
- Site Reference Id/investigator# 2127
Greenbrae, California, United States
- Site Reference Id/investigator# 2417
Fort Collins, Colorado, United States
- Site Reference Id/investigator# 5690
Torrington, Connecticut, United States
- Site Reference Id/investigator# 2411
Fort Lauderdale, Florida, United States
- Site Reference Id/investigator# 3363
Lakeland, Florida, United States
- Site Reference Id/investigator# 3352
Port Saint Lucie, Florida, United States
- Site Reference Id/investigator# 3807
Atlanta, Georgia, United States
- Site Reference Id/investigator# 3353
Chicago, Illinois, United States
- Site Reference Id/investigator# 3359
Indianapolis, Indiana, United States
- Site Reference Id/investigator# 2244
Baltimore, Maryland, United States
- Site Reference Id/investigator# 2416
Baltimore, Maryland, United States
- Site Reference Id/investigator# 2401
Bethesda, Maryland, United States
- Site Reference Id/investigator# 3793
Peabody, Massachusetts, United States
- Site Reference Id/investigator# 3362
Worcester, Massachusetts, United States
- Site Reference Id/investigator# 2075
Kalamazoo, Michigan, United States
- Site Reference Id/investigator# 2418
Jefferson City, Missouri, United States
- Site Reference Id/investigator# 4170
St Louis, Missouri, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Nov 2006
- Primary completion
- 31 Jan 2009
- Completion
- 31 Jan 2009
- Last update posted
- 31 Jan 2013
- Registered enrollment
- 165
- Registry id
- NCT00297089
Cross-registrations
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.